SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 195.61 |
| Enterprise Value ($M) | 155.23 |
| Book Value ($M) | 30.71 |
| Book Value / Share | 0.61 |
| Price / Book | 6.37 |
| NCAV ($M) | 28.97 |
| NCAV / Share | 0.58 |
| Price / NCAV | 6.75 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.96 |
| Return on Assets (ROA) | -0.76 |
| Return on Equity (ROE) | -1.63 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 6.89 |
| Current Ratio | 8.08 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 123.33 |
| Assets | 125.07 |
| Liabilities | 94.36 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Lytton Laurence W | 5.90 | 61.35 | |
| 13G/A | Lundbeckfond Invest A/S | 5.70 | -10.05 | |
| 13G/A | King Luther Capital Management Corp | 4.60 | 0.97 | |
| 13D/A | Orbimed Advisors Llc | 12.10 | 8.99 | |
| 13G/A | BlackRock Inc. | 4.99 | -3.32 | |
| 13G/A | Armistice Capital, Llc | 0.00 | -100.00 | |
| 13G/A | 5AM Ventures IV, L.P. | 3.30 | -56.10 | |
| 13G | Rubric Capital Management LP | 9.76 | ||
| 13G/A | Hirschman Orin | 8.70 | 21.82 | |
| 13G/A | Cowen Financial Products LLC | 0.00 | -100.00 | |
| 13G/A | Millennium Management Llc | 1.00 | -79.29 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,593,385 | 4,100,233 | 38.86 | |
| 119,664 | 375,403 | 31.88 | |
| 69,910 | 326,113 | 21.44 | |
| 21,448 | 126,742 | 16.92 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| RVMD – Revolution Medicines, Inc. | RXRX – Recursion Pharmaceuticals, Inc. |
| SANA – Sana Biotechnology, Inc. | SDGR – Schrödinger, Inc. |
| SLDB – Solid Biosciences Inc. |
Financial data and stock pages provided by
Fintel.io